Men w/PCa on AS: Risk of Prostate Cancer Progression Lower the Healthier Your Diet is Per USDA's HEI скачать в хорошем качестве

Men w/PCa on AS: Risk of Prostate Cancer Progression Lower the Healthier Your Diet is Per USDA's HEI

Men with prostate cancer on active surveillance have a lower risk of progression the healthier the diet is per USDA's Health Eating Index (HEI). [Excerpt} Blue Cure Men's Health Podcast. Dr. Christian Pavlovich, MD is Bernard Schwartz Distinguished Professor in Urologic Oncology at the Brady Urological Institute, Johns Hopkins School of Medicine.#ProstateCancer More: Study Suggests a Healthy Diet May Help Keep Low Grade Prostate Cancer From Progressing to More Dangerous States During Active Surveillance https://www.hopkinsmedicine.org/news/... About Christian Pavlovich, MD Dr. Christian Pavlovich is Bernard L. Schwartz Distinguished Professor in Urologic Oncology at the Johns Hopkins University School of Medicine and Director of the Prostate Cancer Active Surveillance Program at the Brady Urological Institute. Dr. Pavlovich treats cancer with an emphasis on minimizing morbidity and maximizing quality of life while offering patients the latest treatment options and techniques. His clinical focus is on prostate and kidney cancer, and on clinical trials regarding detection, surveillance, and immunotherapy. With more than 20 years of experience with minimally-invasive surgery for the treatment of urologic cancers, he is expert in robotic surgery and was named one of the top prostate cancer surgeons in the United States by Newsweek in 2024. In addition, he offers patients modern diagnostic biopsy techniques, and for prostate cancer patients active surveillance and ablative options including cryotherapy and TULSA. Dr. Pavlovich grew up in Washington DC, went to Harvard University, and then earned his medical degree at the University of California, San Francisco (UCSF) School of Medicine. He then completed a urology residency at New York Hospital-Cornell Medical Center and a National Cancer Institute SUO fellowship in urologic oncology before joining the Hopkins faculty in 2001. Dr. Pavlovich has published over 150 peer-reviewed articles, is Associate Editor of The Prostate and is on the Editorial Board of the British Journal of Urology International. He was the inaugural Director of the Brady Urological Institute’s SUO Urologic Oncology Fellowship (2014 -2024) and is the recipient of three “best teaching/research mentor” awards from the Urology residents at Johns Hopkins. Dr. Pavlovich speaks English, French, Spanish, German, and Serbo-Croatian. He enjoys spending time with his wife and children, following their pursuits, and skiing, diving, running, wildlife, and the great outdoors. About Gabe Canales Gabe Canales has lived with low-risk prostate cancer since 2010, when he was diagnosed at age 35. He is the author of Unexpected Diagnosis: Prostate Cancer and the Wake-Up Call to Live Healthier and Happier, the founder of the nonprofit Blue Cure Foundation, and advocates for prostate cancer patients, and men's health issues. About Blue Cure Blue Cure is a 501c3 nonprofit organization, founded by Gabe Canales, who was diagnosed in 2010 with early-stage prostate cancer at age 35. The Mission of Blue Cure is to save men from premature death, by empowering men with the knowledge that lifestyle choices can prevent and reduce the risk of leading causes of male death from lifestyle-driven chronic health conditions and cancers. Blue Cure wants to end the stigma that keeps men from taking control of their health to live healthier, happier lives. BlueCure.org #menshealth #urology #bradyurology #prostate #diet #foodismedicine #lifestyle #lifestylemedicine #plantbased #johnshopkinsmedicine #cancer #cancercare #endprostatecancer #endcancer